Özet:

Purpose: Laparoscopic sleeve gastrectomy (LSG) has become a widely used primary bariatric surgical technique in recent years. We aimed to investigate the short and mid-term effectiveness of LSG in weight loss and its effects on comorbid type 2 diabetes and hypertension (HT). Materials and Methods:  Eighty-two patients who underwent LSG between January 2009 and December 2011 and whose postoperative 6-month, 1-year, and 3-year follow-up records were available were included in this retrospective study. Preoperative height/weight values, comorbidities, using drugs for HT and/or type 2 diabetes, and changes in postoperative 6-month, 1-year, 3-year, and 5-year data were noted. Results: When we compared with the preoperative data, decrease in body mass index (BMI) at the postoperative 6-month, 1-year, and 3-year follow-ups was statistically significant (p=0.0001, for each). An increase in BMI was observed at 3-year follow-up than at 1-year follow-up (p=0.0001). Decrease in using diabetes medication and antihypertensive drug use was observed at postoperative 3 years compared with the preoperative data (p=0.0001, for each). Conclusion: LSG, which can be applied as a primary treatment in surgical treatment of morbid obesity, is a very effective and reliable method with low mortality and morbidity rates. In addition, it provides significant improvements in comorbidities such as type 2 diabetes and HT. Although there is some weight gain in the mid-term, the short and mid-term results of LSG showed that it is an effective surgical technique.